Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fast versus standard quetiapine titration for bipolar I manic episode
2004-003826-92Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of quetiapine in bipolar I disorder (2 arms), sponsored by AstraZeneca. Primary endpoints: Withdrawals due to adverse events at end of week 1 and Total adverse events reported at end of week 1. Started Nov 2005; status: completed.
02
Drugs
quetiapine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on 2004-003826-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003826-92.